4 completed, 1 unknown, 1 withdrawn. 2 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Colonic Pseudo-Obstruction: new trials by email Literature Review of Colonic Pseudo-Obstruction trials Research Report on Colonic Pseudo-Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neostigmine Route for Acute Colonic Pseudo Obstruction Neostigmine - Ogilvie Syndrome | Phase 4 | Unknown | University of Southern California | 90 | 2022-02-04 | 2023-08-25 |
| Epidural for Ogilvie's Syndrome Epidural anesthesia - Ogilvie Syndrome, Colonic Pseudo-Obstruction | Not applicable | Withdrawn | McMaster University | 2021-09-01 | 2023-01-09 | |
| Therapeutic Oxygen for Gastrointestinal Atony (TOGA) 100% Oxygen - Ileus, Ogilvie Syndrome | Phase 1 | Completed | University of Florida | 17 | 2018-01-25 | 2019-12-12 |
| Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) Eluxadoline, Placebo - Irritable Bowel Syndrome | Phase 3 | Completed | Furiex Pharmaceuticals, Inc | 1146 | 2012-05-29 | 2018-07-30 |
| Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea Eluxadoline, Placebo - Irritable Bowel Syndrome | Phase 2 | Completed | Furiex Pharmaceuticals, Inc | 807 | 2010-04-28 | 2019-10-22 |
| Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery Luminal stents, Minimally Invasive Surgical Bowel Diversion - Large Bowel Obstruction | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 180 | 2002-12-01 | 2007-12-10 |
Colonic Diseases (2) · Colonic Diseases, Functional (2) · Diarrhea (2) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Irritable Bowel Syndrome (2) · Signs and Symptoms, Digestive (2) · Ileus (1) · Intestinal Perforation (1)
Intestinal Obstruction (6) · Intestinal Pseudo-Obstruction (6) · Ileus (5) · Colonic Diseases (4) · Colonic Diseases, Functional (4) · Digestive System Diseases (4) · Gastrointestinal Diseases (4) · Intestinal Diseases (4) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
eluxadoline (2) · Anesthesia, Epidural (1) · Neostigmine (1) · Oxygen (1)
Furiex Pharmaceuticals, Inc (2) · McMaster University (1) · Memorial Sloan Kettering Cancer Center (1) · University of Florida (1) · University of Southern California (1)
United States (5) · Canada (2) · Puerto Rico (1) · United Kingdom (1)
Brian C. Weiner, MD (1) · Hans Gerdes, M.D. (1) · Meghan Lewis, MD (1)
PMID 28167156, PMID 23583433, PMID 24813429, PMID 26789872, PMID 39131150